Live feed
Filing
SC 13D/A
SC 13D/A0001193125-22-315361·Frazier Life Sciences Public Fund, L.P.
Schedule 13D ownership disclosure
KalVista Pharmaceuticals Inc
Security class unavailable · CUSIP: 483497103
Event date: 2022-12-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-315361
- Form type
- SC 13D/A
- Filer
- Frazier Life Sciences Public Fund, L.P.
- CIK
- CIK 1863769
- Filed
- Dec 30, 2022
- Reporting period
- Dec 28, 2022
- Description
- Schedule 13D beneficial ownership